Journal of VitreoRetinal Diseases

Scope & Guideline

Innovating treatments for complex retinal conditions.

Introduction

Delve into the academic richness of Journal of VitreoRetinal Diseases with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2474-1264
PublisherSAGE PUBLICATIONS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2017 to 2024
AbbreviationJ VITREORETINAL DIS / J. Vitreoretinal Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The Journal of VitreoRetinal Diseases focuses on advancing the understanding and treatment of diseases affecting the vitreous and retinal structures of the eye. It encompasses a wide range of clinical and experimental studies aimed at improving patient outcomes through innovative surgical techniques, therapeutic strategies, and diagnostic advancements.
  1. Clinical Outcomes of Vitreoretinal Surgery:
    Research addressing the effectiveness and safety of various vitreoretinal surgical procedures, including vitrectomy and scleral buckling, with a focus on visual and anatomical outcomes.
  2. Innovative Therapeutic Approaches:
    Exploration of new treatment modalities for retinal diseases, including pharmacological interventions, surgical techniques, and novel drug delivery systems.
  3. Imaging Techniques and Diagnostics:
    Utilization of advanced imaging technologies, such as optical coherence tomography (OCT) and multimodal imaging, to improve diagnostic accuracy and monitor disease progression.
  4. Risk Factors and Epidemiology:
    Studies investigating the risk factors, prevalence, and demographics of retinal diseases, emphasizing the importance of understanding population-specific trends.
  5. Patient-Centered Care and Outcomes:
    Research focusing on patient experiences, quality of life, and the socio-economic aspects of retinal disease management, including disparities in treatment access.
Recent publications in the Journal of VitreoRetinal Diseases indicate several emerging themes that reflect the current trends in vitreoretinal research, highlighting innovative approaches and areas of increasing interest.
  1. Telemedicine and Remote Monitoring:
    With the rise of telehealth, there is an increasing focus on utilizing telemedicine for the management and screening of retinal diseases, particularly in light of the COVID-19 pandemic.
  2. Artificial Intelligence and Machine Learning:
    Research exploring the application of AI and machine learning in diagnosing and predicting outcomes in retinal diseases is on the rise, showcasing its potential to revolutionize patient care.
  3. Long-Term Outcomes and Health Disparities:
    There is a growing emphasis on studying long-term outcomes of treatments and understanding health disparities among different demographic groups, which is crucial for improving equity in healthcare.
  4. Novel Drug Delivery Systems:
    Emerging research is focusing on innovative drug delivery platforms, such as sustained-release implants, that enhance the effectiveness and safety of treatments for retinal diseases.
  5. Multimodal Imaging Innovations:
    Advancements in imaging techniques, particularly OCT and angiography, are becoming increasingly prominent, allowing for better disease monitoring and tailored treatment approaches.

Declining or Waning

Over the years, certain themes within the Journal of VitreoRetinal Diseases have seen a decline in focus, reflecting shifts in research priorities and advancements in technology and treatment options.
  1. Traditional Laser Treatments:
    There has been a noticeable reduction in publications centered around conventional laser therapies, as the field moves towards more advanced and less invasive treatment modalities such as anti-VEGF therapies and newer surgical techniques.
  2. Basic Science Research:
    While foundational research remains important, there appears to be a waning interest in purely laboratory-based studies in favor of clinical and translational research that directly impacts patient care.
  3. Outdated Surgical Techniques:
    Publications describing older surgical methods, such as traditional scleral buckling techniques, are becoming less frequent as newer techniques and technologies gain traction.

Similar Journals

Journal of Ophthalmic & Vision Research

Advancing the Frontiers of Eye Care
Publisher: KNOWLEDGE EISSN: 2008-2010Frequency: 4 issues/year

The Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.

Taiwan Journal of Ophthalmology

Bridging knowledge and practice in ophthalmology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2211-5056Frequency: 4 issues/year

Taiwan Journal of Ophthalmology is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by Wolters Kluwer Medknow Publications, this journal has been a vital resource for researchers, practitioners, and students since its inception in 2012. With an ISSN of 2211-5056 and an E-ISSN of 2211-5072, it provides a platform for sharing innovative research, clinical findings, and reviews pertinent to eye health and vision science. The journal is indexed in Scopus and currently holds a Q3 quartile ranking within the ophthalmology category, reflecting its commitment to quality and relevance in the medical community. Located in Mumbai, India, Taiwans Journal of Ophthalmology aims to foster discussions and disseminate knowledge that promotes better understanding and treatment of ocular diseases, ensuring that the latest advancements reach a global audience. By embracing open-access policies, the journal underscores its dedication to making valuable insights readily available to all interested parties, thus contributing significantly to the discourse in ophthalmic research.

Clinical Ophthalmology

Connecting researchers for a brighter vision future.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1177-5483Frequency: 1 issue/year

Clinical Ophthalmology is a leading Open Access journal published by Dove Medical Press Ltd, dedicated to advancing the field of ophthalmology through peer-reviewed research and clinical studies. With a strong impact factor and ranked in the Q1 category of ophthalmology as of 2023, this journal is recognized for its significant contribution to the body of knowledge pertaining to eye health, vision science, and clinical practice. Its Scopus ranking places it within the top 30% of journals in the field, reflecting its influence and relevance in both academic and clinical landscapes. Since its inception in 2007, Clinical Ophthalmology has established a reputation for fostering high-quality research, providing a platform for researchers, professionals, and students to share their findings and insights. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, supporting innovation and collaboration in the pursuit of better patient outcomes worldwide. For those engaged in ophthalmological research and clinical practice, Clinical Ophthalmology serves as an invaluable resource and a hub for the latest developments in the field.

DOCUMENTA OPHTHALMOLOGICA

Cultivating Expertise: Dedicated to the Evolution of Ophthalmology
Publisher: SPRINGERISSN: 0012-4486Frequency: 6 issues/year

DOCUMENTA OPHTHALMOLOGICA is a prestigious journal published by SPRINGER, dedicated to advancing the field of ophthalmology since its inception in 1938. With a robust ISSN of 0012-4486 and an E-ISSN of 1573-2622, the journal has consistently delivered high-quality research, meriting a Q2 classification in Ophthalmology and a Q3 classification in both Physiology and Sensory Systems as of 2023. Located in the Netherlands at VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, DOCUMENTA OPHTHALMOLOGICA aims to publish rigorous studies, reviews, and innovations that bridge clinical practice and research. Although it does not currently offer Open Access options, the journal remains vital for researchers, professionals, and students seeking to stay abreast of developments in visual sciences and contribute to foundational knowledge in these domains.

SURVEY OF OPHTHALMOLOGY

Fostering Scholarly Discourse in Ophthalmology
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

CURRENT EYE RESEARCH

Fostering Collaboration for Eye Health Advancements
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Elevating Knowledge in Ophthalmology for Better Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

JOURNAL FRANCAIS D OPHTALMOLOGIE

Elevating clinical practices with cutting-edge findings.
Publisher: MASSON EDITEURISSN: 0181-5512Frequency: 10 issues/year

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

OPHTHALMIC RESEARCH

Connecting Researchers for a Brighter Future in Eye Health
Publisher: KARGERISSN: 0030-3747Frequency: 6 issues/year

Ophthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.

Translational Vision Science & Technology

Exploring New Horizons in Eye Health and Technology
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.